Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Sanderling Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Sanderling Ventures

Sanderling Ventures

Operating

Sanderling Ventures: A venture capital firm investing in biotech, healthcare, and medical sectors in the US and Canada.

Location
San Mateo, CA, US
Founded
1979
Firm
Compare
Portfolio
Employees
Website

Investments

Glycomine
Glycomine

Total Raised

$80M

Rounds

3

Series B$35MJune 2021
Series B$33MAugust 2019
Series A$12MNovember 2016
ViaCyte
ViaCyte
Public

Total Raised

$235.5M

Rounds

15

Series D$32.6MMarch 2020
Series D$80MNovember 2018
Series C$10.6MJuly 2013
Series C$25MJuly 2007
Metavention
Metavention
Acquired

Total Raised

$65M

Rounds

1

Series C$65MJanuary 2018
Sotera Wireless
Sotera Wireless

Total Raised

$96.3M

Rounds

11

Series Unknown$20.7MApril 2014
Series D$14.8MFebruary 2013
Series D$12.2MDecember 2011
Series C$10.8MApril 2010
Series B$20.3MMarch 2008
Theravida
Theravida
Acquired

Total Raised

$13.7M

Rounds

4

Series Unknown$1MApril 2012
Debt Financing$3.6MJuly 2010
Chimerix
Chimerix
Public

Total Raised

$518.2M

Rounds

15

Series F$45MFebruary 2011
Series E$16.1MAugust 2009
Series D$23.1MFebruary 2007
Trinity Biosystems
Trinity Biosystems

Total Raised

$30M

Rounds

3

Series A$7.5MNovember 2009
Novostent
Novostent

Total Raised

$14.4M

Rounds

3

Series Unknown$1.1MJune 2009
Axikin Pharmaceuticals
Axikin Pharmaceuticals
Public

Total Raised

$18.5M

Rounds

5

Series A$3MJanuary 2009
Asteres
Asteres

Total Raised

$8M

Rounds

4

Series Unknown$4MJune 2008
Series C$4MNovember 2007
Naviscan
Naviscan

Total Raised

$26.8M

Rounds

6

Series C$15MMay 2007
Cylene Pharmaceuticals
Cylene Pharmaceuticals

Total Raised

$102.3M

Rounds

6

Series C$44MJanuary 2007